These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 28452968)

  • 1. Immunomodulatory effect of stereotactic ablative radiotherapy in lung cancer.
    Domagała-Kulawik J
    Pol Arch Intern Med; 2017 Apr; 127(4):233-234. PubMed ID: 28452968
    [No Abstract]   [Full Text] [Related]  

  • 2. Non-surgical treatment of lung cancer: personalised stereotactic ablative radiotherapy.
    Tsang MW; Kam MK; Leung SF; Chan AT
    Hong Kong Med J; 2014 Dec; 20(6):529-36. PubMed ID: 25256817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotactic ablative radiation therapy for primary lung tumors.
    Heinzerling JH; Kavanagh B; Timmerman RD
    Cancer J; 2011; 17(1):28-32. PubMed ID: 21263264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Stereotactic ablative irradiation for lung cancer].
    Antoni D; Srour I; Noël G; Mornex F
    Cancer Radiother; 2014; 18(4):297-307. PubMed ID: 24907006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A radiation oncologist's and thoracic surgeon's view on the role of stereotactic ablative radiotherapy for operable lung cancer.
    Timmerman RD; Fernando HC
    Semin Thorac Cardiovasc Surg; 2013; 25(1):8-13. PubMed ID: 23800524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. It is not just about surgery versus stereotactic ablative radiotherapy, it is about curing as many patients with lung cancer as possible.
    Brunelli A
    J Thorac Cardiovasc Surg; 2018 Sep; 156(3):1247-1248. PubMed ID: 29754789
    [No Abstract]   [Full Text] [Related]  

  • 7. Stereotactic ablative body radiotherapy for lung cancer.
    Franks KN; Jain P; Snee MP
    Clin Oncol (R Coll Radiol); 2015 May; 27(5):280-9. PubMed ID: 25746732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical efficacy of stereotactic ablative radiotherapy for lung metastases arising from colorectal cancer.
    Jung J; Song SY; Kim JH; Yu CS; Kim JC; Kim TW; Jeong SY; Kim SS; Choi EK
    Radiat Oncol; 2015 Nov; 10():238. PubMed ID: 26588896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CyberKnife stereotactic ablative radiotherapy for lung tumors.
    Gibbs IC; Loo BW
    Technol Cancer Res Treat; 2010 Dec; 9(6):589-96. PubMed ID: 21070081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic ablative radiotherapy for pulmonary oligometastases and oligometastatic lung cancer.
    Shultz DB; Filippi AR; Thariat J; Mornex F; Loo BW; Ricardi U
    J Thorac Oncol; 2014 Oct; 9(10):1426-33. PubMed ID: 25170641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic body radiation therapy (stereotactic ablative radiotherapy) for stage I non-small cell lung cancer--updates of radiobiology, techniques, and clinical outcomes.
    Hadziahmetovic M; Loo BW; Timmerman RD; Mayr NA; Wang JZ; Huang Z; Grecula JC; Lo SS
    Discov Med; 2010 May; 9(48):411-7. PubMed ID: 20515609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are the reported clinical outcomes with stereotactic ablative radiotherapy generalizable?
    Senan S; Senthi S
    J Thorac Oncol; 2013 Aug; 8(8):995-6. PubMed ID: 23857397
    [No Abstract]   [Full Text] [Related]  

  • 13. Stereotactic ablative radiotherapy (SABR) for non-small cell lung cancer.
    Iyengar P; Westover K; Timmerman RD
    Semin Respir Crit Care Med; 2013 Dec; 34(6):845-54. PubMed ID: 24258574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Available evidence on re-irradiation with stereotactic ablative radiotherapy following high-dose previous thoracic radiotherapy for lung malignancies.
    De Bari B; Filippi AR; Mazzola R; Bonomo P; Trovò M; Livi L; Alongi F
    Cancer Treat Rev; 2015 Jun; 41(6):511-8. PubMed ID: 25913714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship Between Tumor Location and Outcome in Patients With Early-Stage Lung Cancer.
    Dahele M; Damhuis RA
    Clin Lung Cancer; 2017 Sep; 18(5):e367-e368. PubMed ID: 28522159
    [No Abstract]   [Full Text] [Related]  

  • 16. Stereotactic ablative radiotherapy for centrally located early stage non-small-cell lung cancer: what we have learned.
    Chang JY; Bezjak A; Mornex F;
    J Thorac Oncol; 2015 Apr; 10(4):577-85. PubMed ID: 25514807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary atelectasis after stereotactic ablative radiotherapy for a central lung tumor.
    Senthi S; Ullmann EF; Senan S
    J Thorac Oncol; 2013 Nov; 8(11):e94-5. PubMed ID: 24128724
    [No Abstract]   [Full Text] [Related]  

  • 18. Creating a Sustainable Future of Radiotherapy Following COP26: A Case for Lung Stereotactic Ablative Radiotherapy Over Surgery?
    Stanford-Edwards C; Edwards M; Selby A; Lewis R; Powell C; Nicholas O
    Clin Oncol (R Coll Radiol); 2022 Mar; 34(3):e105-e106. PubMed ID: 34895991
    [No Abstract]   [Full Text] [Related]  

  • 19. Stereotactic ablative radiotherapy for medically inoperable early stage lung cancer: early outcomes.
    Chan OS; Yeung RM; Hung AW; Lee MC; Chang AT; Chan CC; Lee AW
    Hong Kong Med J; 2012 Oct; 18(5):412-8. PubMed ID: 23018069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic Ablative Body Radiotherapy (SABR) in Pulmonary Oligometastatic/Oligorecurrent Non-small Cell Lung Cancer Patients: A New Therapeutic Approach.
    Agolli L; Valeriani M; Nicosia L; Bracci S; De Sanctis V; Minniti G; Enrici RM; Osti MF
    Anticancer Res; 2015 Nov; 35(11):6239-45. PubMed ID: 26504057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.